Cargando…
2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights
In this study, different assortments of 2-arylquinolines and 2,6-diarylquinolines have been developed. Recently, we have developed a new series of 6,7-dimethoxy-4-alkoxy-2-arylquinolines as Topoisomerase I (TOP1) inhibitors with potent anticancer activity. Utilising the SAR outputs from this study,...
Autores principales: | Elbadawi, Mostafa M., Eldehna, Wagdy M., Abd El-Hafeez, Amer Ali, Somaa, Warda R., Albohy, Amgad, Al-Rashood, Sara T., Agama, Keli K., Elkaeed, Eslam B., Ghosh, Pradipta, Pommier, Yves, Abe, Manabu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725837/ https://www.ncbi.nlm.nih.gov/pubmed/34923887 http://dx.doi.org/10.1080/14756366.2021.2015344 |
Ejemplares similares
-
Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights
por: Al-Warhi, Tarfah, et al.
Publicado: (2022) -
Multi-stage structure-based virtual screening approach towards identification of potential SARS-CoV-2 NSP13 helicase inhibitors
por: El Hassab, Mahmoud A., et al.
Publicado: (2022) -
Organocatalytic atroposelective heterocycloaddition to access axially chiral 2-arylquinolines
por: Yang, Gongming, et al.
Publicado: (2021) -
Screening of the antileishmanial and antiplasmodial potential of synthetic 2-arylquinoline analogs
por: Espinosa-Saez, Roger, et al.
Publicado: (2023) -
Olive Leaves as a Potential Phytotherapy in the Treatment of COVID-19 Disease; A Mini-Review
por: Abdelgawad, Shimaa M., et al.
Publicado: (2022)